NACC2

Chr 9

NACC family member 2

Also known as: BEND9, BTBD14, BTBD14A, BTBD31, NAC-2, RBB

The protein functions as a transcriptional repressor that associates with the NuRD complex to repress MDM2 transcription, leading to p53 stabilization. Based on the tolerance metrics provided (pLI = 0.31, LOEUF = 0.75), NACC2 appears relatively tolerant to loss-of-function variants, but no specific disease associations or inheritance patterns are documented in the available data.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
0
P/LP submissions
P/LP missense
0.75
LOEUF
Mechanism
Clinical SummaryNACC2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.75LOEUF
pLI 0.315
Z-score 2.04
OE 0.24 (0.100.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.73Z-score
OE missense 0.64 (0.550.75)
120 obs / 186.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.100.75)
00.351.4
Missense OE0.64 (0.550.75)
00.61.4
Synonymous OE1.20
01.21.6
LoF obs/exp: 2 / 8.4Missense obs/exp: 120 / 186.5Syn Z: -1.42

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NACC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC